Kemin becomes majority shareholder in animal vaccine company Middle East for Vaccines
An ingredient manufacturer Kemin Industries is growing its presence in the global vaccine market by becoming majority shareholder of Middle East for Vaccines (MEVAC), an animal vaccine manufacturer based in Cairo, Egypt, and a shareholder in MEVAC’s sister company, UVAC, to further expand Kemin’s portfolio in the global animal vaccine market